IncFact
Company Profiles: Revenue, Growth, Competition

CEPHALON Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Cephalon

Access the complete profile.

Cephalon Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry5417 Scientific Research & Development Services
Address41 Moores Road
Frazer, PA 19355

Note: Revenues for privately held companies are statistical evaluations.


Cephalon's annual revenues are over $500 million (see exact revenue data). It is classified as operating in the Scientific Research & Development Services industry.


Cephalon's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Cephalon Annual Revenue and Growth Rate

Cephalon Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Cephalon's revenues are gauged from an analysis of company filings.



Cephalon's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Cephalon Revenue (Sales) Cephalon Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Cephalon is developing and marketing. Cephalon doesn't have any recent trademark applications, indicating Cephalon is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
VANTRELA ER (HYDROCODONE BITARTRATE) EXTENDED-RELEASE TABLETS
Pharmaceutical preparations featuring hydrocodone bitartrate for the treatment of pain
06/07/2016
VANTRELA ER ( HYDROCODONE BITARTRATE) EXTENDED-RELEASE TABLETS
Pharmaceutical preparations featuring hydrocodone bitartrate for the treatment of pain
06/07/2016
VELZETO
Pharmaceutical preparations for the treatment of pain
04/25/2016

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Cephalon's intellectual property, its current capabilities and future direction. Cephalon has applied for 106 patents since 2009. Cephalon's most recent patent was filed in March 2018 for Inhalation Systems, Devices And Methods. Digital systems, devices and methods for managing a drug therapy, such as an anti-IL5 mAb or anti-IL5 receptor mAb treatment regimen for patients suffering from severe asthma (e.g., eosinophilic asthma), are provided. The digital systems, devices and methods may include hardware and software for predicting patient responses to a long term anti-IL5 mAb or anti-IL5 receptor mAb treatment based on clinical data obtained following an initial treatment period.


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Cephalon grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Cephalon is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Cephalon vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Cephalon, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SYNEOS HEALTHRaleigh, NC100 
ALEXION PHARMACEUTICALSNew Haven, CT88 
LEIDOS HOLDINGSReston, VA79 
CEPHALONFrazer, PA70 
VERTEX PHARMACEUTICALSBoston, MA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM59 




Nearby Competitors

These companies are similar in business line and location to Cephalon. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
CEPHALONFrazer, PA100 
ENDO PHARMACEUTICALSMalvern, PA16 
NEURONETICSMalvern, PA2 
FRONTAGE LABORATORIESExton, PA2 
ALLIANCE PHARMAMalvern, PA0 
STROUD WATER RESEARCH CENTERAvondale, PA0 




Similar Sized Companies near Frazer

These are similar in size and location to Cephalon.

Company HeadquartersRevenue ($ MM)
TRIUMPH GROUPBerwyn, PA21 
SAINT-GOBAINMalvern, PA25 
TRINSEO S.A.Berwyn, PA31 
GENESIS ADMINISTRATIVE SERVICESKennett Square, PA36 
QVCWest Chester, PA57 
RICOH USAMalvern, PA100 
VISHAY INTERTECHNOLOGYMalvern, PA20 
SIEMENS MEDICAL SOLUTIONS USAMalvern, PA14 
PQ GROUP HOLDINGSMalvern, PA10 
COMMUNICATIONS TEST DESIGNWest Chester, PA9 
TITANIUM METALSExton, PA7 
DFC GLOBALBerwyn, PA7 




Fastest Growing Competitors

These companies are in the same general field as Cephalon and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Cephalon Competitors